5tmg
From Proteopedia
(Difference between revisions)
| Line 7: | Line 7: | ||
Description: Optimization of 3,5-Disubstitued Piperidine: Discovery of Non-Peptide mimetics as an Orally Active Renin Inhibitor | Description: Optimization of 3,5-Disubstitued Piperidine: Discovery of Non-Peptide mimetics as an Orally Active Renin Inhibitor | ||
[[Category: Unreleased Structures]] | [[Category: Unreleased Structures]] | ||
| + | [[Category: Lane, W]] | ||
[[Category: Okada, K]] | [[Category: Okada, K]] | ||
[[Category: Snell, G.P]] | [[Category: Snell, G.P]] | ||
[[Category: Sang, B.C]] | [[Category: Sang, B.C]] | ||
| - | [[Category: Lane, W]] | ||
[[Category: Hideyuki, O]] | [[Category: Hideyuki, O]] | ||
[[Category: Behnke, C.A]] | [[Category: Behnke, C.A]] | ||
Revision as of 13:24, 27 September 2017
Unreleased structure
The entry 5tmg is ON HOLD until Paper Publication
Authors: Snell, G.P., Behnke, C.A., Okada, K., Hideyuki, O., Sang, B.C., Lane, W.
Description: Optimization of 3,5-Disubstitued Piperidine: Discovery of Non-Peptide mimetics as an Orally Active Renin Inhibitor
